Details for New Drug Application (NDA): 050571
✉ Email this page to a colleague
The generic ingredient in CEFMAX is cefmenoxime hydrochloride. There is one drug master file entry for this compound. Additional details are available on the cefmenoxime hydrochloride profile page.
Summary for 050571
Tradename: | CEFMAX |
Applicant: | Tap Pharm |
Ingredient: | cefmenoxime hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 050571
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Dec 30, 1987 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Dec 30, 1987 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Dec 30, 1987 | TE: | RLD: | No |
Complete Access Available with Subscription